Pasithea Therapeutics Corp (NASDAQ:KTTA) currently has a daily average trading volume of 5.53M but it saw 4213565 shares traded in last market. With a market cap of 3.35M USD, the company’s current market price of $1.13 came falling about -25.66 while comparing to the previous closing price of $1.52. In past 52 weeks, the stock remained buoying in the range of price level as high as $7.69 and as low as $0.92.
Taking a look at 20-day trading activity of Pasithea Therapeutics Corp (KTTA) gives us an average price of $1.4695, while its current price level is -85.31% below from 52-week high level whereas it is 22.48% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $1.3052 while that of 200 days or SMA-200 reads an average of $3.0392. A closer look into the stock’s movement over the week reveals that its volatility is standing at 51.12% during that period while stretching the period over a month that decreases to 25.20%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 38.72 which implies that the stock is in neutral territory.
Over the week, KTTA’s stock price is moving -31.93% down while it is -6.61% when we observe its performance for the past one month. Year-to-date it is -64.13% down and over the past year, the stock is showing a downside performance of -83.74%.
Currently, Pasithea Therapeutics Corp’s total number of outstanding shares is 2.96M with 8.99% of that held by the insiders while 4.83% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -94.06% and return on equity (ROE) at -72.83%. Stock’s beta reads 0.54. Stock has a price to book (P/B) ratio of 0.11. Its return on asset (ROA) is -65.93% on average.
